Vena cava

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 270 Experts worldwide ranked by ideXlab platform

H.-d. Weiss - One of the best experts on this subject based on the ideXlab platform.

Dwight Davis - One of the best experts on this subject based on the ideXlab platform.

  • Orthotopic heart transplantation with preoperative unsuspected left superior Vena cava and absence of right superior Vena cava.
    Journal of Heart and Lung Transplantation, 1992
    Co-Authors: Reed D. Quinn, Barry S. Clemson, John L. Myers, Dwight Davis
    Abstract:

    We report the case history of a 47-year-old man who underwent orthotopic heart transplantation for ischemic cardiomyopathy. At the time of cardiectomy, the patient was found to have a persistent left superior Vena cava draining into the coronary sinus and complete absence of his right superior Vena cava. The donor heart had been removed without knowledge of this venous anomaly; consequently, the donor's superior Vena cava and innominate vein were not harvested. The persistent left superior Vena cava was cannulated for cardiopulmonary bypass. The recipient's heart was excised along the atrial ventricular groove, preserving the persistent left superior Vena cava and coronary sinus. The atrial cuffs of the recipient and donor were fashioned for atrial-to-atrial anastomoses. Successful endomyocardial biopsies have been performed through the femoral veins after transplantation.

Paul Scott - One of the best experts on this subject based on the ideXlab platform.

Heike Lorch - One of the best experts on this subject based on the ideXlab platform.

Daniel M. Becker - One of the best experts on this subject based on the ideXlab platform.

  • Vena cava filter devices.
    Clinics in Chest Medicine, 1995
    Co-Authors: Kenneth A. Ballew, John T. Philbrick, Daniel M. Becker
    Abstract:

    : Vena cava filters are effective in preventing pulmonary embolism (PE) in patients with deep vein thrombosis or PE who either have contraindications to anticoagulation or have sustained a PE despite adequate anticoagulation. Although Vena cava filters are not without complications, clinically significant morbidity and mortality are low. The use of Vena cava filters as primary prophylaxis or therapy for deep vein thrombosis and PE should await the results of controlled trials.